Relapsed and refractory malignant rhabdoid tumors – Evaluation of new therapeutic approaches
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
Augsburg, Universität Augsburg, Dissertation, 2024
- Schlagwort
-
Krebs
Therapie
Tumor
Kind
Krebs
Tumorregister
Therapieerfolg
Evaluation
Kind
Säugling
- Ereignis
-
Veröffentlichung
- (wo)
-
Augsburg
- (wer)
-
Universität Augsburg
- (wann)
-
2025
- Urheber
- Beteiligte Personen und Organisationen
-
Frühwald, Michael C.
- URN
-
urn:nbn:de:bvb:384-opus4-1179895
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:25 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Steinbügl, Mona Juliane
- Frühwald, Michael C.
- Universität Augsburg
Entstanden
- 2025
Ähnliche Objekte (12)
Current and emerging therapeutic approaches for extracranial malignant rhabdoid tumors
An exceptional response to nivolumab in relapsed and refractory malignant mesothelioma
Therapeutic options in relapsed or refractory peripheral T-cell lymphoma
Apoptotic response of malignant rhabdoid tumor cells
Malignant extrarenal rhabdoid tumor: a case report
Fetal-onset malignant rhabdoid tumor: a case report
Dissecting genetic pathways in schwannomatosis and malignant rhabdoid tumour
Current and New Therapeutic Strategies for Relapsed and Refractory Multiple Myeloma: An Update
Prenatal Diagnosis of Renal Rhabdoid Tumor: A Rare Malignant Neoplasm
X‐linked inhibitor of apoptosis protein represents a promising therapeutic target for relapsed/refractory ALL
Tazemetostat in the therapy of pediatric INI1-negative malignant rhabdoid tumors
Moxetumomab pasudotox in relapsed/refractory hairy cell leukemia
Current and emerging therapeutic approaches for extracranial malignant rhabdoid tumors
An exceptional response to nivolumab in relapsed and refractory malignant mesothelioma
Therapeutic options in relapsed or refractory peripheral T-cell lymphoma
Apoptotic response of malignant rhabdoid tumor cells
Malignant extrarenal rhabdoid tumor: a case report
Fetal-onset malignant rhabdoid tumor: a case report
Dissecting genetic pathways in schwannomatosis and malignant rhabdoid tumour
Current and New Therapeutic Strategies for Relapsed and Refractory Multiple Myeloma: An Update
Prenatal Diagnosis of Renal Rhabdoid Tumor: A Rare Malignant Neoplasm
X‐linked inhibitor of apoptosis protein represents a promising therapeutic target for relapsed/refractory ALL
Tazemetostat in the therapy of pediatric INI1-negative malignant rhabdoid tumors
Moxetumomab pasudotox in relapsed/refractory hairy cell leukemia
Current and emerging therapeutic approaches for extracranial malignant rhabdoid tumors
An exceptional response to nivolumab in relapsed and refractory malignant mesothelioma
Therapeutic options in relapsed or refractory peripheral T-cell lymphoma
Apoptotic response of malignant rhabdoid tumor cells
Malignant extrarenal rhabdoid tumor: a case report
Fetal-onset malignant rhabdoid tumor: a case report
Dissecting genetic pathways in schwannomatosis and malignant rhabdoid tumour
Current and New Therapeutic Strategies for Relapsed and Refractory Multiple Myeloma: An Update
Prenatal Diagnosis of Renal Rhabdoid Tumor: A Rare Malignant Neoplasm
X‐linked inhibitor of apoptosis protein represents a promising therapeutic target for relapsed/refractory ALL
Tazemetostat in the therapy of pediatric INI1-negative malignant rhabdoid tumors